Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-25-103763
Filing Date
2025-04-29
Accepted
2025-04-29 16:05:26
Documents
15
Period of Report
2025-06-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A d908829ddef14a.htm   iXBRL DEF 14A 464339
3 GRAPHIC g908829g11s01.jpg GRAPHIC 33278
4 GRAPHIC g908829g11s02.jpg GRAPHIC 137854
5 GRAPHIC g908829g11s03.jpg GRAPHIC 233293
  Complete submission text file 0001193125-25-103763.txt   1806408

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA sepn-20241231.xsd EX-101.SCH 2498
17 EXTRACTED XBRL INSTANCE DOCUMENT d908829ddef14a_htm.xml XML 5099
Mailing Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080
Business Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080 650-338-3533
Septerna, Inc. (Filer) CIK: 0001984086 (see all company filings)

EIN.: 843891440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-42382 | Film No.: 25887123
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)